Startup Term Sheets

Is a signed term sheet a financing?#

No. A signed term sheet records serious intent, but cash arrives only after satisfactory diligence, investor approval, negotiation of definitive documents, board and stockholder approvals, charter and securities filings, and satisfaction of closing conditions.

The NVCA maintains model U.S. financing documents that map to distinct functions:

The term sheet should be specific enough that these documents implement the deal rather than reopen its central economics and control.

Why do term sheets matter more than they look?#

Leverage inverts at signature. Before signing, a founder may have several financing paths. After signing a binding no-shop, the company often cannot solicit alternatives while the investor conducts diligence — and runway keeps shrinking. Terms that looked secondary become hard to reopen.

Headline valuation does not determine founder proceeds. Two term sheets can state identical pre-money valuations and produce very different outcomes through option-pool timing, participating preferred, the liquidation multiple, cumulative dividends, seniority, redemption, tranche conditions, and anti-dilution.

Governance outlasts the cash. Board composition and protective provisions affect budgets, executive hiring, future financings, debt, pool increases, acquisitions, and charter amendments. An investor may own 20% and still hold approval rights over actions common holders would otherwise control. Percentage ownership, board control, and class vetoes are three separate control systems — check all three.

Early terms set precedent. Rights granted at Series A are routinely requested by later investors or carried into a senior stack. A small concession compounds across Series B and C. Negotiate the architecture, not just the immediate dollar impact.

What are the economic terms?#

Investment amount and security. Identify round size, lead and participating investors, primary versus secondary proceeds, the preferred series, initial and later closings, and whether commitments are firm or conditional. Secondary purchases give cash to selling holders, not the company — never count them in runway.

Pre-money valuation and price per share. The term sheet must define fully diluted capitalization: does it include the existing unissued pool, the pool top-up, outstanding and promised options, warrants, SAFEs, and notes with interest? If that definition is unresolved, ownership is unresolved.

Option pool. State the target unallocated pool after closing, whether outstanding awards count, whether top-up shares sit in the pre-money, and the hiring plan that justifies the size. A pre-money top-up dilutes existing holders without touching the investor's negotiated percentage — see the worked model in Dilution and Cap Tables.

Liquidation preference. Specify the multiple, participating or nonparticipating, any participation cap, seniority relative to existing preferred, dividend treatment, what counts as a liquidation event, and conversion mechanics. Covered in depth in Liquidation Preferences.

Dividends. Distinguish noncumulative dividends payable only if declared from cumulative or accruing dividends that increase the preference. An 8% cumulative dividend materially raises the exit hurdle over several years even when no cash is ever paid.

Anti-dilution. A future issuance below the current preferred price may trigger broad-based weighted-average, narrow-based weighted-average, or full-ratchet adjustment. The charter formula and its exceptions matter — ordinary employee grants, strategic issuances, and equipment leases are often excluded.

Pro rata rights. A right to invest more cash to maintain ownership — not protection from dilution without investment. Define eligibility threshold, covered issuances, calculation basis, notice period, transferability, and termination.

Redemption. A right to require the company to repurchase shares after a period, subject to law and available funds. Rarely exercised, but it creates leverage and a balance-sheet overhang.

What are the control terms?#

Board composition. Specify size, which seats are elected by preferred, common, or all holders, founder-designated seats, the independent seat, who selects and approves the independent, observer rights, and vacancy handling. A five-seat board described as "two founders, two investors, one independent" is not neutral if the investor holds effective veto over the independent.

Protective provisions. Preferred holders may require class approval to change preferred rights, create senior or pari passu securities, sell or liquidate the company, declare dividends, repurchase stock, take on debt above a threshold, change board size, or amend the charter. Apparently technical language — such as blocking creation of a new series — can function as approval rights over your next financing.

Founder vesting and acceleration. Review credit for already-earned vesting, the remaining schedule, cliff, repurchase price, termination treatment, single- versus double-trigger acceleration, and treatment of a role change. Resetting a founder's entire schedule transfers substantial economic leverage.

Drag-along, ROFR, and co-sale. A drag-along can require covered holders to support a qualifying sale — check the approving groups, minimum price conditions, escrow allocation, several versus joint liability, and whether holders receive the same form of consideration. ROFR and co-sale protect the cap table but reduce founder liquidity.

What are the process and closing terms?#

Binding versus non-binding. Do not rely on the label. Read exclusivity, confidentiality, expense reimbursement, access, publicity, governing law, and termination. Binding status is a legal conclusion drawn from the whole document and applicable law.

Conditions to closing. "Subject to satisfactory diligence" gives the investor meaningful discretion. Other common conditions: investment committee approval, minimum round size, syndicate participation, corporate approvals, IP assignments, founder agreements, no material adverse change, and required filings. Clarify known issues before exclusivity, not after.

Exclusivity. Match the no-shop period to diligence scope, document readiness, the investor's approval process, syndicate formation, and — critically — your runway. Include a clear expiration and avoid automatic extension without consent.

Tranches and milestones. For a tranched financing, define each tranche's amount and date, the objective milestone, the measurement source, who determines satisfaction, cure or waiver rights, consequences of partial achievement, and whether price or rights change. The NVCA's October 2025 model-document update added a framework for exactly this, including optional language converting an investor's preferred into common if it fails to fund — stripping its liquidation preference and protective rights on previously purchased shares.

Worked example: same valuation, different exit economics#

Assume a $20M pre-money, $5M new investment, $25M post-money, 20% investor as-converted ownership, and no debt or transaction costs (to isolate the preference).

• Term Sheet A: 1x nonparticipating preferred → max($5M, 20% x exit)
• Term Sheet B: 1x participating preferred, no cap → $5M + 20% x (exit - $5M)

The headline valuation and the 20% ownership are identical. Participation transfers an extra $1.0M, $2.6M, and $4.0M to the investor across the three scenarios.

Conversion breakpoint under A. The investor converts once 20% of proceeds exceeds the $5M preference: $5M / 20% = $25M. Below a $25M exit it takes the preference; above it, converting pays more.

Caveats. This model assumes a single preferred series, no debt, no transaction costs, no accrued dividends, and no option exercise proceeds — every one of which shifts the numbers in practice. The "common" column also lumps together founders, employees, and the unissued pool, so a founder's individual share is smaller than it appears. Real waterfalls stack multiple series with differing seniority; treat this as the shape of the effect, not a forecast.

Sources#

1. National Venture Capital Association. Model Legal Documents and 2025 Updates to Model Legal Documents.
2. Wilson Sonsini Goodrich & Rosati. What Do Definitive Agreements for a Series A Financing Look Like?.
3. Cooley GO. Negotiating Term Sheets. Practitioner guidance on valuation, preference, board, protective provisions, vesting, anti-dilution, and exclusivity.
4. Cooley. Q1 2026 Venture Financing Report and Cooley GO Data. Observed U.S. venture-financing terms.
5. U.S. Securities and Exchange Commission. Small Business Glossary and Common Startup Securities.

Educational note: This page explains financing terms for founders. It is not legal, tax, accounting, or investment advice. Term-sheet language has binding legal consequences — have qualified counsel review the actual document before you sign.